Relaxo Footwears (RELAXO) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
1 Jun, 2026Executive summary
Q4 FY26 revenue grew 8.1% year-over-year to INR 751 crores, while FY26 revenue declined to between INR 2,702 crores and INR 2,748.36 crores from the previous year.
FY26 PAT rose 5.3% to INR 179 crores, with Q4 FY26 PAT up 20.4% year-over-year to INR 68 crores.
EBITDA margin for FY26 was 13.8%, with Q4 FY26 EBITDA margin improving to 16.5%.
Volume sold in FY26 was 17.5 crore pairs, marginally down from 17.8 crore in FY25, but average realization per pair increased to INR 153.
The Board recommended a final dividend of INR 3.50 per share, totaling INR 87.13 crore for FY26.
Financial highlights
FY26 revenue: INR 2,702–2,748.36 crores (down year-over-year); Q4 FY26 revenue: INR 751 crores (up 8.1% year-over-year).
FY26 PAT: INR 179 crores (up 5.3% year-over-year); Q4 FY26 PAT: INR 68 crores (up 20.4% year-over-year).
FY26 EBITDA: INR 374 crores (down 2.1% year-over-year); Q4 FY26 EBITDA: INR 124 crores (up 10.7% year-over-year).
FY26 EBIT margin: 9.7%; PAT margin: 6.6%; ROE: 8.3%; ROCE: 12.1%.
Basic and diluted EPS for FY26 were INR 7.20, up from INR 6.84 in FY25.
Outlook and guidance
Management remains cautiously optimistic for FY27, targeting at least 1% operating margin improvement over FY26’s 13.8%.
Volume growth of 4%-5% is targeted over the next two years, with focus on premiumization and product mix improvement.
The Board’s dividend recommendation signals confidence in future cash flows and profitability.
Indian footwear market expected to grow at 9.7% CAGR to INR 4,433 billion by 2034, with organized sector expanding at 13% CAGR.
Focus on product innovation, digital transformation, and expanding distribution to capture growth opportunities.
Latest events from Relaxo Footwears
- Q1FY25 revenue increased 1.3% year-over-year, but net profit and margins declined.RELAXO
Q1 24/2518 Jun 2026 - Q3FY26 saw stable revenue but lower profit, while FY25 ended with strong cash and growth outlook.RELAXO
Q3 25/2630 Jan 2026 - Revenue and profit declined, margins stable, CapEx over INR 100 crore, cash flow improved.RELAXO
Q2 24/2515 Jan 2026 - Margins stable despite lower sales; growth expected as distribution revamp settles.RELAXO
Q4 24/2521 Nov 2025 - Revenue and profit margins declined, but cash flow and long-term outlook remain strong.RELAXO
Q2 25/2614 Nov 2025 - Q1FY26 profit and EPS rose despite lower revenue, with margin gains and strong cash flow.RELAXO
Q1 25/2631 Jul 2025 - Q3 FY25 revenue and profit fell, but credit ratings and industry outlook remain strong.RELAXO
Q3 24/255 Jun 2025